{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:41:08Z","timestamp":1793814068781,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01271-5","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T21:55:02Z","timestamp":1769810102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metagenomics indicates an interplay of the microbiome and functional pathways in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Sarah Jaehwa","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar\u0131\u015f Erhan","family":"\u00d6zdin\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn Grace","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon J.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Farahnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Boomgaarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie K.","family":"Mischley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"1271_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson\u2019s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1271_CR2","doi-asserted-by":"publisher","first-page":"II3","DOI":"10.1007\/PL00007758","volume":"247","author":"H Braak","year":"2000","unstructured":"Braak, H. & Braak, E. Pathoanatomy of Parkinson\u2019s disease. J. Neurol. 247, II3\u2013II10 (2000).","journal-title":"J. Neurol."},{"key":"1271_CR3","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","volume":"260","author":"MG Cersosimo","year":"2013","unstructured":"Cersosimo, M. G. et al. Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms. J. Neurol. 260, 1332\u20131338 (2013).","journal-title":"J. Neurol."},{"key":"1271_CR4","doi-asserted-by":"crossref","unstructured":"Skj\u00e6rb\u00e6k, C., Knudsen, K., Horsager, J. & Borghammer P. Gastrointestinal dysfunction in Parkinson\u2019s Disease. J. Clin. Med. 10, 493 (2010).","DOI":"10.3390\/jcm10030493"},{"key":"1271_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.955919","volume":"14","author":"J Zeng","year":"2022","unstructured":"Zeng, J., Wang, X., Pan, F. & Mao, Z. The relationship between Parkinson\u2019s disease and gastrointestinal diseases. Front. Aging Neurosci. 14, 955919 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1271_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp-2015-311680","volume":"87","author":"KL Adams-Carr","year":"2016","unstructured":"Adams-Carr, K. L. et al. Constipation preceding Parkinson\u2019s disease: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 87, 710\u2013716 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1271_CR7","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.parkreldis.2014.09.026","volume":"20","author":"CH Lin","year":"2014","unstructured":"Lin, C. H., Lin, J. W., Liu, Y. C., Chang, C. H. & Wu, R. M. Risk of Parkinson\u2019s disease following severe constipation: a nationwide population-based cohort study. Park. Relat. Disord. 20, 1371\u20131375 (2014).","journal-title":"Park. Relat. Disord."},{"key":"1271_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/ane.13570","volume":"145","author":"S Lu","year":"2022","unstructured":"Lu, S., Jiang, H. Y. & Shi, Y. D. Association between irritable bowel syndrome and Parkinson\u2019s disease: a systematic review and meta-analysis. Acta Neurol. Scand. 145, 442\u2013448 (2022).","journal-title":"Acta Neurol. Scand."},{"key":"1271_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.720958","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Association between irritable bowel syndrome and risk of parkinson\u2019s disease: a systematic review and meta-analysis. Front. Neurol. 12, 720958 (2021).","journal-title":"Front. Neurol."},{"key":"1271_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.dld.2018.09.017","volume":"51","author":"F Zhu","year":"2019","unstructured":"Zhu, F. et al. The risk of Parkinson\u2019s disease in inflammatory bowel disease: A systematic review and meta-analysis. Dig. Liver Dis. 51, 38\u201342 (2019).","journal-title":"Dig. Liver Dis."},{"key":"1271_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.parkreldis.2017.06.011","volume":"42","author":"A Macerollo","year":"2017","unstructured":"Macerollo, A. et al. Colonic diverticular disease: a new risk factor for Parkinson\u2019s disease?. Park. Relat. Disord. 42), 61\u201365 (2017).","journal-title":"Park. Relat. Disord."},{"key":"1271_CR12","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak, A. Bonaz B. Brain-gut-microbiota axis in Parkinson\u2019s disease. World J. Gastroenterol. 21(, 10609\u201310620 (2015).","journal-title":"World J. Gastroenterol."},{"key":"1271_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainres.2018.01.010","volume":"1693","author":"RA Liddle","year":"2018","unstructured":"Liddle, R. A. Parkinson\u2019s disease from the gut. Brain Res. 1693, 201\u2013206 (2018).","journal-title":"Brain Res."},{"key":"1271_CR14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480.e12 (2016).","journal-title":"Cell"},{"key":"1271_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"Sun, M. F. & Shen, Y. Q. Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s Disease. Ageing Res. Rev. 45, 53\u201361 (2018).","journal-title":"Ageing Res. Rev."},{"key":"1271_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1866974","volume":"13","author":"Y Bhattarai","year":"2021","unstructured":"Bhattarai, Y. et al. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson\u2019s disease. Gut Microbes 13, 1866974 (2021).","journal-title":"Gut Microbes"},{"key":"1271_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf, J. R. et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med. 9, 39 (2017).","journal-title":"Genome Med."},{"key":"1271_CR18","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen, S. J. et al. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98, e848\u2013e858 (2022).","journal-title":"Neurology"},{"key":"1271_CR19","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","volume":"143","author":"Y Qian","year":"2020","unstructured":"Qian, Y. et al. Gut metagenomics-derived genes as potential biomarkers of Parkinson\u2019s disease. Brain 143, 2474\u20132489 (2020).","journal-title":"Brain"},{"key":"1271_CR20","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00253-023-12489-1","volume":"107","author":"S Nie","year":"2023","unstructured":"Nie, S. et al. The link between increased Desulfovibrio and disease severity in Parkinson\u2019s disease. Appl Microbiol. Biotechnol. 107, 3033\u20133045 (2023).","journal-title":"Appl Microbiol. Biotechnol."},{"key":"1271_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian, Y. et al. Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav. Immun. 70, 194\u2013202 (2018).","journal-title":"Brain Behav. Immun."},{"key":"1271_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41531-022-00351-6","volume":"8","author":"S Jo","year":"2022","unstructured":"Jo, S. et al. Oral and gut dysbiosis leads to functional alterations in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 87 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1271_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105187","volume":"160","author":"Z Yan","year":"2021","unstructured":"Yan, Z. et al. Alterations of gut microbiota and metabolome with Parkinson\u2019s disease. Micro. Pathog. 160, 105187 (2021).","journal-title":"Micro. Pathog."},{"key":"1271_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41531-023-00612-y","volume":"9","author":"SJ Chen","year":"2023","unstructured":"Chen, S. J. et al. Plasma metabolites of aromatic amino acids associate with clinical severity and gut microbiota of Parkinson\u2019s disease. NPJ Parkinsons Dis. 9, 165 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1271_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41531-024-00724-z","volume":"10","author":"H Nishiwaki","year":"2024","unstructured":"Nishiwaki, H. et al. Meta-analysis of shotgun sequencing of gut microbiota in Parkinson\u2019s disease. NPJ Parkinsons Dis. 10, 106 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1271_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/ana.26454","volume":"92","author":"C Bolliri","year":"2022","unstructured":"Bolliri, C. et al. Gut microbiota in monozygotic twins discordant for Parkinson\u2019s disease. Ann. Neurol. 92, 631\u2013636 (2022).","journal-title":"Ann. Neurol."},{"issue":"Feb","key":"1271_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.01.005","volume":"95","author":"E De Pablo-Fernandez","year":"2022","unstructured":"De Pablo-Fernandez, E. et al. The faecal metabolome and mycobiome in Parkinson\u2019s disease. Park. Relat. Disord. 95(Feb), 65\u201369 (2022).","journal-title":"Park. Relat. Disord."},{"key":"1271_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JPD-202237","volume":"11","author":"MS Cirstea","year":"2021","unstructured":"Cirstea, M. S. et al. The gut mycobiome in Parkinson\u2019s Disease. J. Parkinsons Dis. 11, 153\u2013158 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"1271_CR29","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/mds.29959","volume":"39","author":"A Metcalfe-Roach","year":"2024","unstructured":"Metcalfe-Roach, A. et al. Metagenomic analysis reveals large-scale disruptions of the gut microbiome in Parkinson\u2019s disease. Mov. Disord. 39, 1740\u20131751 (2024).","journal-title":"Mov. Disord."},{"key":"1271_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"ZD Wallen","year":"2022","unstructured":"Wallen, Z. D. et al. Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat. Commun. 13, 6958 (2022).","journal-title":"Nat. Commun."},{"key":"1271_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.29300","volume":"38","author":"JC Boktor","year":"2023","unstructured":"Boktor, J. C. et al. Integrated multi-cohort analysis of the Parkinson\u2019s disease gut metagenome. Mov. Disord. 38, 399\u2013409 (2023).","journal-title":"Mov. Disord."},{"key":"1271_CR32","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022\u20131023 (2006).","journal-title":"Nature"},{"key":"1271_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2180-9-123","volume":"9","author":"D Mariat","year":"2009","unstructured":"Mariat, D. et al. The Firmicutes\/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9, 123 (2009).","journal-title":"BMC Microbiol."},{"key":"1271_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12866-017-1027-1","volume":"17","author":"A Koliada","year":"2017","unstructured":"Koliada, A. et al. Association between body mass index and Firmicutes\/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 17, 120 (2017).","journal-title":"BMC Microbiol."},{"key":"1271_CR35","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/nu12051474","volume":"12","author":"F Magne","year":"2020","unstructured":"Magne, F. et al. The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?. Nutrients 12, 1474 (2020).","journal-title":"Nutrients"},{"key":"1271_CR36","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/microorganisms8111715","volume":"8","author":"S Stojanov","year":"2020","unstructured":"Stojanov, S., Berlec, A. & \u0160trukelj, B. The influence of probiotics on the firmicutes\/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms 8, 1715 (2020).","journal-title":"Microorganisms"},{"key":"1271_CR37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic, A. D., Xavier, R. J. & Gevers, D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146, 1489\u20131499 (2014).","journal-title":"Gastroenterology"},{"key":"1271_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4161\/auto.7.4.13074","volume":"7","author":"TS Stappenbeck","year":"2011","unstructured":"Stappenbeck, T. S. et al. Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy 7, 355\u2013374 (2011).","journal-title":"Autophagy"},{"key":"1271_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104700","volume":"134","author":"Z Chen","year":"2020","unstructured":"Chen, Z., Li, G. & Liu, J. Autonomic dysfunction in Parkinson\u2019s disease: implications for pathophysiology, diagnosis, and treatment. Neurobiol. Dis. 134, 104700 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1271_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger, M. M. et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Park. Relat. Disord. 32, 66\u201372 (2016).","journal-title":"Park. Relat. Disord."},{"key":"1271_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/mds.27304","volume":"33","author":"A Mulak","year":"2018","unstructured":"Mulak, A. A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson\u2019s disease. Mov. Disord. 33, 398\u2013401 (2018).","journal-title":"Mov. Disord."},{"key":"1271_CR42","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan, A. H. et al. Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics. Ann. Neurol. 89, 546\u2013559 (2021).","journal-title":"Ann. Neurol."},{"key":"1271_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VTE Aho","year":"2021","unstructured":"Aho, V. T. E. et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol. Neurodegener. 16, 6 (2021).","journal-title":"Mol. Neurodegener."},{"key":"1271_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.728479","volume":"12","author":"L Mao","year":"2021","unstructured":"Mao, L. et al. Cross-sectional study on the gut microbiome of Parkinson\u2019s disease patients in Central China. Front Microbiol 12, 728479 (2021).","journal-title":"Front Microbiol"},{"key":"1271_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.dld.2018.02.012","volume":"50","author":"C Binda","year":"2018","unstructured":"Binda, C. et al. Actinobacteria: a relevant minority for the maintenance of gut homeostasis. Dig. Liver Dis. 50, 421\u2013428 (2018).","journal-title":"Dig. Liver Dis."},{"key":"1271_CR46","doi-asserted-by":"publisher","first-page":"10400","DOI":"10.1073\/pnas.1601060113","volume":"113","author":"P Manrique","year":"2016","unstructured":"Manrique, P. et al. Healthy human gut phageome. Proc. Natl. Acad. Sci. USA 113, 10400\u201310405 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1271_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29173-4","volume":"8","author":"G Tetz","year":"2018","unstructured":"Tetz, G., Brown, S. M., Hao, Y. & Tetz, V. Parkinson\u2019s disease and bacteriophages as its overlooked contributors. Sci. Rep. 8, 10812 (2018).","journal-title":"Sci. Rep."},{"key":"1271_CR48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1212\/WNL.0000000000002307","volume":"86","author":"HH Tsai","year":"2016","unstructured":"Tsai, H. H. et al. Hepatitis C virus infection as a risk factor for Parkinson disease: a nationwide cohort study. Neurology 86, 840\u2013846 (2016).","journal-title":"Neurology"},{"key":"1271_CR49","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00702-022-02536-y","volume":"129","author":"V Leta","year":"2022","unstructured":"Leta, V. et al. Viruses, parkinsonism and Parkinson\u2019s disease: the past, present and future. J. Neural Transm. 129, 1119\u20131132 (2022).","journal-title":"J. Neural Transm."},{"key":"1271_CR50","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","volume":"1792","author":"H Jang","year":"2009","unstructured":"Jang, H., Boltz, D. A., Webster, R. G. & Smeyne, R. J. Viral Parkinsonism. Biochim. Biophys. Acta 1792, 714\u2013721 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"1271_CR51","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41401-020-0375-9","volume":"41","author":"JHM Prehn","year":"2020","unstructured":"Prehn, J. H. M. & Jirstr\u00f6m, E. Angiogenin and tRNA fragments in Parkinson\u2019s disease and neurodegeneration. Acta Pharm. Sin. 41, 442\u2013446 (2020).","journal-title":"Acta Pharm. Sin."},{"key":"1271_CR52","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7150\/thno.51963","volume":"11","author":"X Yu","year":"2021","unstructured":"Yu, X. et al. tRNA-derived fragments: mechanisms underlying their regulation of gene expression and potential applications as therapeutic targets in cancers and virus infections. Theranostics 11, 461\u2013469 (2021).","journal-title":"Theranostics"},{"key":"1271_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.parkreldis.2019.05.035","volume":"65","author":"R Magee","year":"2019","unstructured":"Magee, R., Londin, E. & Rigoutsos, I. TRNA-derived fragments as sex-dependent circulating candidate biomarkers for Parkinson\u2019s disease. Park. Relat. Disord. 65, 203\u2013209 (2019).","journal-title":"Park. Relat. Disord."},{"key":"1271_CR54","doi-asserted-by":"publisher","first-page":"389","DOI":"10.14336\/AD.2021.0903","volume":"13","author":"H Tian","year":"2022","unstructured":"Tian, H., Hu, Z. & Wang, C. The therapeutic potential of tRNA-derived small RNAs in neurodegenerative disorders. Aging Dis. 13, 389\u2013401 (2022).","journal-title":"Aging Dis."},{"key":"1271_CR55","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-021-00775-x","volume":"28","author":"MC Kuo","year":"2021","unstructured":"Kuo, M. C., Liu, S. C. H., Hsu, Y. F. & Wu, R. M. The role of noncoding RNAs in Parkinson\u2019s disease: biomarkers and associations with pathogenic pathways. J. Biomed. Sci. 28, 78 (2021).","journal-title":"J. Biomed. Sci."},{"key":"1271_CR56","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s13311-016-0497-4","volume":"14","author":"S Paganoni","year":"2017","unstructured":"Paganoni, S. & Schwarzschild, M. A. Urate as a marker of risk and progression of neurodegenerative disease. Neurotherapeutics 14, 148\u2013153 (2017).","journal-title":"Neurotherapeutics"},{"key":"1271_CR57","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3233\/JAD-220432","volume":"90","author":"Q Aerqin","year":"2022","unstructured":"Aerqin, Q. et al. Serum uric acid levels in neurodegenerative disorders: a cross-sectional study. J. Alzheimers Dis. 90, 761\u2013773 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"1271_CR58","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/mds.29209","volume":"37","author":"F Seifar","year":"2022","unstructured":"Seifar, F., Dinasarapu, A. R. & Jinnah, H. A. Uric acid in Parkinson\u2019s disease: what is the connection?. Mov. Disord. 37, 2173\u20132183 (2022).","journal-title":"Mov. Disord."},{"key":"1271_CR59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/medicina58020245","volume":"58","author":"A D\u0103n\u0103u","year":"2022","unstructured":"D\u0103n\u0103u, A., Dumitrescu, L., Lefter, A. & Popescu, B. O. Serum uric acid levels in parkinson\u2019s disease: a cross-sectional electronic medical record database study from a tertiary Referral Centre in Romania. Medicina 58, 245 (2022).","journal-title":"Medicina"},{"key":"1271_CR60","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s10072-021-05558-8","volume":"43","author":"X Shi","year":"2022","unstructured":"Shi, X. et al. Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson\u2019s disease. Neurol. Sci. 43,1747\u20131754 (2022).","journal-title":"Neurol. Sci."},{"key":"1271_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18071\/isz.75.0051","volume":"75","author":"BC Ari","year":"2022","unstructured":"Ari, B. C., Tur, E. K., Domac, F. M. & Kenangil, G. O. Uric acid: the role in the pathophysiology and the prediction in the diagnosis of Parkinson\u2019s disease: a Turkish-based study. Ideggyogy. Sz. 75, 51\u201359 (2022).","journal-title":"Ideggyogy. Sz."},{"key":"1271_CR62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.29245\/2578-3009\/2018\/2.1122","volume":"2","author":"B Sartor","year":"2018","unstructured":"Sartor, B. Intestinal bacterial biofilms modulate mucosal immune responses. J. Immunol. Sci. 2, 13\u201318 (2018).","journal-title":"J. Immunol. Sci."},{"key":"1271_CR63","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000477990","volume":"9","author":"E Stolzenberg","year":"2017","unstructured":"Stolzenberg, E. et al. A role for neuronal Alpha-Synuclein in gastrointestinal immunity. J. Innate Immun. 9, 456\u2013463 (2017) .","journal-title":"J. Innate Immun."},{"key":"1271_CR64","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.isci.2019.08.047","volume":"19","author":"D Christodoulou","year":"2019","unstructured":"Christodoulou, D. et al. Reserve flux capacity in the pentose phosphate pathway by NADPH binding is conserved across kingdoms. iScience 19, 1133\u20131144 (2019).","journal-title":"iScience"},{"key":"1271_CR65","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM De Vos","year":"2022","unstructured":"De Vos, W. M., Tilg, H., Van Hul, M. & Cani, P. D. Gut microbiome and health: mechanistic insights. Gut 71, 1020\u20131032 (2022).","journal-title":"Gut"},{"key":"1271_CR66","doi-asserted-by":"publisher","first-page":"1019430","DOI":"10.3389\/fnut.2022.1019430","volume":"9","author":"J Hou","year":"2022","unstructured":"Hou, J., Xiang, J., Li, D., Liu, X. & Pan, W. Gut microbial response to host metabolic phenotypes. Front. Nutr. 9, 1019430 (2022).","journal-title":"Front. Nutr."},{"key":"1271_CR67","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41591-020-01183-8","volume":"27","author":"F Asnicar","year":"2021","unstructured":"Asnicar, F. et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat. Med. 27, 321\u2013332 (2021).","journal-title":"Nat. Med."},{"key":"1271_CR68","unstructured":"Bushnell, B. BBDuk Guide. DOE Joint Genome Institute. Berkeley (CA): U.S. Department of Energy; 2021. Available from: https:\/\/jgi.doe.gov\/data-and-tools\/software-tools\/bbtools\/bb-tools-user-guide\/bbdukguide\/."},{"key":"1271_CR69","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41592-018-0176-y","volume":"15","author":"EA Franzosa","year":"2018","unstructured":"Franzosa, E. A. et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat. Methods 15, 962\u2013968 (2018).","journal-title":"Nat. Methods"},{"key":"1271_CR70","doi-asserted-by":"publisher","first-page":"D471","DOI":"10.1093\/nar\/gkv1164","volume":"44","author":"R Caspi","year":"2016","unstructured":"Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway\/genome databases. Nucleic Acids Res. 44, D471\u2013D480 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1271_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).","journal-title":"Genome Biol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01271-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:03:01Z","timestamp":1772632981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01271-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01271-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7209227\/v1","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.E.O., D.M.W., and K.M. were employed by CosmosID Inc at the time of the study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}